Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Michael Myers

Tracked across 2 events · 13 articles · First seen Jul 09, 2026 · Last active Sep 08, 2026

Sentiment
5
Attention
2
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 10
Regulatory
Impact: As CEO of Quoin Pharmaceuticals, Dr. Michael Myers commented on the significance of the FDA clearance for patients with Peeling Skin Syndrome.
Jul 09, 2026 · 7 articles
2 0
Regulatory
On September 8, 2026, the U.S. United States — Food and Drug Administration granted Rare Pediatric Disease (RPD) Designation to Quoin Pharmaceuticals' lead asset, QRX003, for the treatment of Peeling Skin Syndrome (PSS). This is…
Impact: Michael Myers is the CEO of Quoin Pharmaceuticals and is quoted in the announcement, representing the company's leadership.
Sep 08, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Michael Myers live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.